Total:€ 429,00
Perimenopause & Hormone Metabolism Insight – Women Essential + Vital Balance
€ 499,00
A combined blood and 24-hour urine assessment for the perimenopausal transition. It pairs circulating reproductive, pituitary, thyroid, adrenal and cardiometabolic markers with detailed estrogen, progesterone and androgen metabolites and hormone-pathway ratios.
Beschrijving
WHL Integrated Women’s Health Panel
Perimenopause & Hormone Metabolism Insight
Women Essential Perimenopause + Vital Balance 24-Hour Urine Hormone Panel
€499
€568
Save €69
€568
Save €69
Why combine these tests?
Blood testing measures circulating hormones and their regulatory context, including FSH, LH, SHBG, thyroid function and cardiometabolic markers. The 24-hour urine profile adds information about hormone production across a full day and how estrogens, progesterone and androgens are metabolised. Together, the tests distinguish hormone levels from downstream metabolism and provide a broader view than either assessment alone.
Test 1 · Blood
Women Essential Perimenopause
Measures FSH, LH, estradiol, progesterone, SHBG, total and free testosterone, DHEA-S, cortisol, a complete thyroid panel, HbA1c, HOMA-IR and a lipid panel.
Test 2 · 24-Hour Urine
Vital Balance Hormone Panel
Provides detailed estrogen, progesterone and androgen assessment, including hydroxy- and methoxy-estrogen metabolites, pathway ratios, pregnanediol metabolites, DHT-related metabolites and 5α-reductase activity.
What the combined panel can help clarify
Perimenopausal endocrine context: FSH, LH, estradiol and progesterone are interpreted alongside cycle history and symptoms rather than as isolated values.
Available androgens: total testosterone, free testosterone, SHBG and DHEA-S add circulating androgen context.
Estrogen metabolism: 2-OH, 4-OH and 16-OH pathways, methoxy estrogens and calculated ratios provide information about downstream estrogen handling.
Progesterone and androgen metabolites: pregnanediols, DHT-related markers, androsterone, etiocholanolone and pathway ratios extend beyond serum hormone concentrations.
Thyroid and metabolic influences: thyroid markers, HbA1c, HOMA-IR and lipids provide context for symptoms such as fatigue, weight change and altered energy.
Hormone-therapy monitoring context: the combined information may support professional review when hormone treatment is being considered or monitored.
Integrated hormone coverage
Reproductive signalling
FSH, LH, estradiol, progesterone, testosterone, SHBG and DHEA-S
FSH, LH, estradiol, progesterone, testosterone, SHBG and DHEA-S
Estrogen pathways
Estrone, estradiol, 2-OH, 4-OH, 16-OH and methoxy metabolites with pathway ratios
Estrone, estradiol, 2-OH, 4-OH, 16-OH and methoxy metabolites with pathway ratios
Androgen & progesterone metabolism
DHT-related metabolites, androsterone, etiocholanolone and pregnanediols
DHT-related metabolites, androsterone, etiocholanolone and pregnanediols
Wider health context
Complete thyroid panel, cortisol, HbA1c, HOMA-IR and lipid profile
Complete thyroid panel, cortisol, HbA1c, HOMA-IR and lipid profile
Who may consider this panel?
- Irregular or changing menstrual cycles
- Hot flushes, night sweats or sleep changes
- Mood, concentration or energy changes during midlife
- Weight, glucose or lipid changes during the transition
- Symptoms requiring thyroid and hormone assessment together
- Professional monitoring of prescribed hormone therapy
Sample requirements
Women Essential: venous blood collected in the WHL-specified tubes.
Vital Balance: all urine collected over a complete 24-hour period using the supplied collection materials.
Planning: blood and urine timing may need to reflect menstrual-cycle stage, symptoms and hormone-therapy schedule.
Before collection
✓ Arrange the collection day with WHL or your practitioner when menstrual cycles are still present or irregular.
✓ Fast according to the WHL instructions because the blood panel includes HOMA-IR and metabolic markers.
✓ Record hormonal contraception, menopausal hormone therapy, corticosteroids and relevant supplements with dose and timing.
✓ Collect every urine void during the specified 24-hour interval and follow the storage and return instructions exactly.
Important: Do not stop prescribed hormones or other medication for testing unless the prescribing healthcare professional gives specific instructions.
Clinical note: Perimenopause is assessed clinically, and hormone concentrations can fluctuate substantially during this transition. This panel supports—not replaces—medical evaluation. Urinary hormone metabolites and pathway ratios do not diagnose or predict hormone-sensitive cancer. New postmenopausal bleeding, very heavy bleeding, a breast lump, severe pelvic pain or other concerning symptoms requires prompt clinical assessment.
